GlassScriptPhysician profile
Sally Ciron
NPI 1134310170
$844.63
in general payments reported to CMS, 2019-2025
9 companies · $535 in 2025
The $535 reported for 2025 was more than what 75% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $310 · 2025: $535.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $845.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $844.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $283.99 | 2024-2025 | Airsupra, Breztri, Farxiga |
| Exact Sciences Corporation | $239.42 | 2024-2025 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $105.59 | 2024-2025 | Gardasil 9, Capvaxive, Gardasil |
| Novo Nordisk INC | $58.49 | 2025 | Ozempic, Rybelsus |
| Lilly USA, LLC | $48.17 | 2025 | Zepbound, Mounjaro |
| Amgen INC. | $41.50 | 2025 | Repatha, Otezla, Repatha |
| Lundbeck LLC | $25.18 | 2025 | Rexulti |
| Glaxosmithkline, LLC. | $21.31 | 2024 | Trelegy Ellipta |
| Shield Therapeutics INC | $20.98 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sally Ciron listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.